Teva And Alvotech Add Indications For US Stelara Rival

Selarsdi Version Of Ustekinumab Approved For Crohn’s Disease And Ulcerative Colitis

 
• By Dave Wallace
  
Selarsdi is now approved for Crohn’s disease and ulcerative colitis (Shutterstock)

More from Biosimilars

More from Generics Bulletin